CXCL12 and IGF1 select for cancer cell populations with enhanced bone metastasis ability
Ontology highlight
ABSTRACT: CXCL12 and IGF1 confer on cancer cells survival advantage. Src potentiates cancer cells' reponse to CXCL12 and IGF1 by strengthening AKT activation. Long-term incubation of CXCL12 and IGF1 select for cancer cells with enhanced Src activity and bone metastasis potential.
ORGANISM(S): Homo sapiens
PROVIDER: GSE39102 | GEO | 2012/12/10
SECONDARY ACCESSION(S): PRJNA170054
REPOSITORIES: GEO
ACCESS DATA